Tokenized Pokémon Card Sales Soar Over 10x in One Year, CARDS Market Cap Surpasses $580 Million
BlockBeats News, June 15th, according to GMGN data, the Solana ecosystem entity card trading platform Collector Crypt's token CARDS has continued to surge in value, breaking through $580 million from its early May value of $200 million, with a nearly $5.4 million 24-hour trading volume.
The on-chain tokenized Pokémon card market has seen explosive growth, with the top seven platforms achieving a capsule toy sales volume of $230 million in May, compared to just $32 million in the same period last year, representing a growth of over 10 times. The core driver is the capsule toy machine mechanism. Users can invest funds to randomly receive NFT card backs, simulating the physical pack opening experience while providing immediate liquidity.
Collector Crypt founder Tuom Holmberg revealed that the capsule toy machine accounts for 90% to 95% of the company's business, and the platform has accumulated sales of over $1 billion in the 18 months since its launch. To dispel concerns in the market about an "exit scam," the company has a 28,000 square foot vault in Montana to store physical card inventory, with some competitors also accessing this vault to gain liquidity and trust endorsements. Holmberg positions the capsule toy machine as a "gamified shopping experience" and claims that the machine provides positive expected value—on average, users can get back $55 for every $50 spent.
The global physical card market reached $15.8 billion last year, and is expected to increase to $23.5 billion by 2030. Despite the fading NFT craze in the crypto space, tokenization technology is once again becoming a key infrastructure for the speculative card market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
